In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
3 days 20 hours ago
3 weeks 3 days ago
8 weeks 1 day ago
11 weeks 1 day ago
11 weeks 1 day ago
20 weeks 2 days ago
21 weeks 16 hours ago
26 weeks 1 day ago
29 weeks 6 days ago
32 weeks 5 days ago